Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-24 @ 7:51 PM
NCT ID:
NCT02151604
Eligibility Criteria:
Inclusion Criteria:
* Participant is willing and able to give informed consent for participation in the trial
* Male or Female, aged 18 years or above
* Histologically verified NSCLC
* Patients with any stage NSCLC where radical radiotherapy (with either conventionally fractionated treatment or with stereotactic body radiotherapy (SABR)) or chemoradiotherapy (concurrent or sequential schedule) is considered appropriate
* WHO performance status 0-2
* Able (in the Investigators opinion) and willing to comply with all study requirements
Exclusion Criteria:
* Inability to give written informed consent
* Female participant who is pregnant, lactating or planning pregnancy during the course of the trial
* Previous radiotherapy to the chest
* The presence of another condition where the disease itself or treatment may interfere with the study endpoints
* Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule
* Inability to lie flat for imaging
* Contraindications to MRI examination including indwelling pacemaker, non-MRI compatible metallic implant, severe claustrophobia, intra-ocular foreign body
* Contraindications for gadolinium enhanced lung MRI scan - known hypersensitivity/allergy to the injection of MultiHance (contains gadobenate dimeglumine and small quantities of benzyl alcohol) that is given as part of this scanning or an adverse reaction to an injection given during previous MRI scanning, severe renal impairment
* Contraindications for ventilation/perfusion nuclear medicine scanning - known hypersensitivity to albumin or preference to avoid blood donation product
* Epilepsy requiring on-going medical treatment, or a seizure within the past year
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02151604
Study Brief:
Protocol Section:
NCT02151604